CoronaCheck™ PR

Cambridge, England, 4 January 2021 – Exhalation Technology Updates on Groundbreaking Clinical Trial for CoronaCheck

New clinical data on the CoronaCheck Covid-19 exhaled breath test shows absolute specificity and sensitivity in a test taking under 5 minutes at under $10.

To read the full press release - Exhalation Technology (ETL) Announces New Clinical Trial for CoronaCheck™ – A Rapid Covid-19 Test for Exhaled Breath

Exhalation Technology (ETL) Announces New Clinical Trial for CoronaCheck™ – A Rapid Covid-19 Test for Exhaled Breath

Exhalation Technology announces a new clinical study with its novel CoronaCheck™ test for Covid-19, aiming for a sub-5 minute test of high specificity and sensitivity

To read the full press release - Exhalation Technology (ETL) Announces New Clinical Trial for CoronaCheck™ – A Rapid Covid-19 Test for Exhaled Breath

Exhalation Technology Announces Global Search for Strategic Partners for its Covid-19 Rapid Diagnostic Test

Cambridge, England, 14 September 2020 – Exhalation Technology has appointed The Sage Group to lead the partnering program for its novel diagnostic test for Covid-19 in exhaled breath condensate. This is a rapid (<5 minutes) test of high specificity and sensitivity for Covid-19, meeting the need for testing in a wide range of environments. 

To read the full press release - Exhalation Technology Announces Global Search for Strategic Partners for its Covid-19 Rapid Diagnostic Test

CoronaCheck™ for Covid-19

Coronavirus spreads through breath, and scientific studies indicate that testing for Covid- 19 in breath could offer true convenience and high reliability. At the Cambridge based start-up Exhalation Medical Technology, we are innovators in breath tests, applying rapid, non-invasive Point of Care technology to a range of respiratory diseases. This is now being applied to coronavirus testing and we are proud to announce funding for the project by Innovate UK, the UK’s innovation agency.

To read the full press release - Press release CoronaCheck™ for Covid-19 - Final Version.pdf